Results 31 to 40 of about 3,788,205 (194)

IL-36α suppresses proliferation of ovarian cancer cells

open access: yesTumor Biology, 2017
Interleukin-36α (IL-36α), also formerly known as IL-1F6, is pertaining to IL-1 family members that has been shown to play an important pro-inflammatory role in chronic immune disorders.
Lei Chang, Ruixia Guo, Zhongfu Yuan
doaj   +1 more source

The Prevalence of Occult Omental Metastases in Patients with Epithelial Ovarian Cancer

open access: yesIndonesian Journal of Obstetrics and Gynecology, 2018
Objective: Studies regarding omentectomy on epithelial ovarian cancer are scarce with conflicting results; this study is aimed to investigate the prevalence of occult metastases in patients with epithelial ovarian cancer of the omentum.
Hariyono Winarto, Ken Indra
doaj   +1 more source

Targeted Therapies in Epithelial Ovarian Cancer [PDF]

open access: yesCancers, 2010
Molecularly targeted therapy is relatively new to ovarian cancer despite the unquestionable success with these agents in other solid tumours such as breast and colorectal cancer. Advanced ovarian cancer is chemosensitive and patients can survive several years on treatment. However chemotherapy diminishes in efficacy over time whilst toxicities persist.
Dean, Emma   +2 more
openaire   +3 more sources

Targeted anti-vascular therapies for ovarian cancer: current evidence [PDF]

open access: yes, 2013
Ovarian cancer presents at advanced stage in around 75% of women, and despite improvements in treatments such as chemotherapy, the 5-year survival from the disease in women diagnosed between 1996 and 1999 in England and Wales was only 36%.
Mcneish, I.   +27 more
core   +1 more source

MiRNA-802 suppresses proliferation and migration of epithelial ovarian cancer cells by targeting YWHAZ

open access: yesJournal of Ovarian Research, 2019
Background The imbalance of expression of microRNA-802 may have a significant place in tumor progression. However, the bio-function of epithelial ovarian cancer cells remains unclear.
Bo Yang, Li Sun, Lei Liang
doaj   +1 more source

The human homologue of unc-93 maps to chromosome 6q27 - characterisation and analysis in sporadic epithelial ovarian cancer [PDF]

open access: yes, 2002
Background: In sporadic ovarian cancer, we have previously reported allele loss at D6S193 (62%) on chromosome 6q27, which suggested the presence of a putative tumour suppressor gene.
Liu, Y   +35 more
core   +1 more source

Functional polymorphisms in FOXC2 gene and Epithelial ovarian Cancer susceptibility in Chinese population

open access: yesJournal of Ovarian Research, 2020
Background Epithelial ovarian cancer (EOC) is highly lethal gynecological cancer. Forkhead Box Protein C2 (FOXC2) promotes occurrence and development of various malignant tumors.
Zhijiao Zhou   +6 more
doaj   +1 more source

Paraneoplastic thrombocytosis in ovarian cancer [PDF]

open access: yes, 2012
<p>Background: The mechanisms of paraneoplastic thrombocytosis in ovarian cancer and the role that platelets play in abetting cancer growth are unclear.</p> <p>Methods: We analyzed clinical data on 619 patients with epithelial ...
Han, H.D.   +33 more
core   +1 more source

Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries. [PDF]

open access: yesPLoS ONE, 2009
MicroRNAs (miRNAs) are small regulatory RNAs that are implicated in cancer pathogenesis and have recently shown promise as blood-based biomarkers for cancer detection.
Stacia K Wyman   +9 more
doaj   +1 more source

Clinical implication for endometriosis associated with ovarian cancer

open access: yesGynecology and Minimally Invasive Therapy, 2017
We reviewed current literature regarding the association of endometriosis and epithelial ovarian cancer based on epidemiology studies, molecular researches and clinical observations. Our methods include a review of literature research of MEDLINE, PubMed,
Pao-Ling Torng
doaj   +1 more source

Home - About - Disclaimer - Privacy